Glucotrack (GCTK) Debt to Equity (2016 - 2020)
Historic Debt to Equity for Glucotrack (GCTK) over the last 7 years, with Q3 2020 value amounting to $0.02.
- Glucotrack's Debt to Equity rose 10885.85% to $0.02 in Q3 2020 from the same period last year, while for Sep 2020 it was $0.02, marking a year-over-year increase of 10885.85%. This contributed to the annual value of -$0.14 for FY2019, which is 13104.66% down from last year.
- According to the latest figures from Q3 2020, Glucotrack's Debt to Equity is $0.02, which was up 10885.85% from $0.02 recorded in Q2 2020.
- In the past 5 years, Glucotrack's Debt to Equity registered a high of $11.77 during Q2 2019, and its lowest value of -$0.22 during Q3 2019.
- Moreover, its 5-year median value for Debt to Equity was -$0.01 (2017), whereas its average is $0.66.
- Over the last 5 years, Glucotrack's Debt to Equity had its largest YoY gain of 11655260.41% in 2019, and its largest YoY loss of 189758.55% in 2019.
- Glucotrack's Debt to Equity (Quarter) stood at -$0.01 in 2016, then grew by 25.49% to -$0.01 in 2017, then crashed by 430.95% to -$0.06 in 2018, then plummeted by 131.05% to -$0.14 in 2019, then skyrocketed by 114.19% to $0.02 in 2020.
- Its Debt to Equity stands at $0.02 for Q3 2020, versus $0.02 for Q2 2020 and $0.02 for Q1 2020.